Literature DB >> 30668912

Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.

Meagan A Quinlan1, Danielle Krout2, Rania M Katamish, Matthew J Robson3, Catherine Nettesheim, Paul J Gresch, Deborah C Mash4, L Keith Henry2, Randy D Blakely.   

Abstract

The antidepressant-sensitive serotonin (5-HT) transporter (SERT) dictates rapid, high-affinity clearance of the neurotransmitter in both the brain and periphery. In a study of families with multiple individuals diagnosed with autism spectrum disorder (ASD), we previously identified several, rare, missense coding variants that impart elevated 5-HT transport activity, relative to wild-type SERT, upon heterologous expression as well as in ASD subject lymphoblasts. The most common of these variants, SERT Ala56, located in the transporter's cytosolic N-terminus, has been found to confer in transgenic mice hyperserotonemia, an ASD-associated biochemical trait, an elevated brain 5-HT clearance rate, and ASD-aligned behavioral changes. Hyperfunction of SERT Ala56 has been ascribed to a change in 5-HT KM, though the physical basis of this change has yet to be elucidated. Through assessments of fluorescence resonance energy transfer (FRET) between cytosolic N- and C-termini, sensitivity to methanethiosulfonates, and capacity for N-terminal tryptic digestion, we obtain evidence for mutation-induced conformational changes that support an open-outward 5-HT binding conformation in vitro and in vivo. Aspects of these findings were also evident with another naturally occurring C-terminal SERT coding variant identified in our ASD study, Asn605. We conclude that biased conformations of surface resident transporters that can impact transporter function and regulation are an unappreciated consequence of heritable and disease-associated SERT coding variation.

Entities:  

Keywords:  autism spectrum disorder; protein conformation; serotonin; serotonin transporter

Mesh:

Substances:

Year:  2019        PMID: 30668912      PMCID: PMC6640095          DOI: 10.1021/acschemneuro.8b00689

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  65 in total

1.  Simultaneous effects of local dexfenfluramine application on extracellular glutamate and serotonin levels in rat frontal cortex: a reverse microdialysis study.

Authors:  C Rocher; C Jacquot; A M Gardier
Journal:  Neuropharmacology       Date:  1999-04       Impact factor: 5.250

2.  FRET or no FRET: a quantitative comparison.

Authors:  Claude Berney; Gaudenz Danuser
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

3.  Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.

Authors:  K P Lesch; B L Wolozin; D L Murphy; P Reiderer
Journal:  J Neurochem       Date:  1993-06       Impact factor: 5.372

4.  Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines.

Authors:  Birgit Hilber; Petra Scholze; Mario M Dorostkar; Walter Sandtner; Marion Holy; Stefan Boehm; Ernst A Singer; Harald H Sitte
Journal:  Neuropharmacology       Date:  2005-09-26       Impact factor: 5.250

5.  The cytoplasmic substrate permeation pathway of serotonin transporter.

Authors:  Yuan-Wei Zhang; Gary Rudnick
Journal:  J Biol Chem       Date:  2006-09-28       Impact factor: 5.157

6.  Enhanced activity of human serotonin transporter variants associated with autism.

Authors:  Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

7.  Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals.

Authors:  A Balcioglu; R J Wurtman
Journal:  Brain Res       Date:  1998-11-30       Impact factor: 3.252

Review 8.  Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins.

Authors:  R D Blakely; S Ramamoorthy; S Schroeter; Y Qian; S Apparsundaram; A Galli; L J DeFelice
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

9.  Mechanism for alternating access in neurotransmitter transporters.

Authors:  Lucy R Forrest; Yuan-Wei Zhang; Miriam T Jacobs; Joan Gesmonde; Li Xie; Barry H Honig; Gary Rudnick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-22       Impact factor: 11.205

10.  The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.

Authors:  Simon Bulling; Klaus Schicker; Yuan-Wei Zhang; Thomas Steinkellner; Thomas Stockner; Christian W Gruber; Stefan Boehm; Michael Freissmuth; Gary Rudnick; Harald H Sitte; Walter Sandtner
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.486

View more
  5 in total

Review 1.  Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo.

Authors:  Carina Meinke; Meagan A Quinlan; Krista C Paffenroth; Fiona E Harrison; Cristina Fenollar-Ferrer; Rania M Katamish; Isabel Stillman; Sammanda Ramamoorthy; Randy D Blakely
Journal:  Neurochem Res       Date:  2021-04-08       Impact factor: 3.996

2.  Serotonin 5-HT1B receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant.

Authors:  Kally C O'Reilly; Michelle Connor; Jamie Pierson; Lauren C Shuffrey; Randy D Blakely; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2021-01-29       Impact factor: 4.530

Review 3.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

4.  Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse.

Authors:  Samantha E Stilley; Randy D Blakely
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

5.  Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner.

Authors:  Durairaj Ragu Varman; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  J Neurochem       Date:  2020-09-07       Impact factor: 5.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.